Continuing Professional Development

The ECPM Continuing Professional Development (CPD) platform provides accredited high quality educational programs to support continuing medical education and professional development for physicians, and pharmaceutical industry, regulatory and university professionals. As such, its primary intention is to provide up-to-date knowledge on current trends in drug development and to train drug development professionals for their next career step. Additionally, it offers a platform to share knowledge with colleagues and discuss with experts face-to-face. Our services include a broad range of CPD short courses that cover all skills across the drug development process. These CPD short courses count towards the Master program, yet they are also a stand-alone offer and can be booked individually to shape your professional skills and are offered in the following formats:

Short Courses/Workshops - A range of interactive onsite short courses/workshops. These cover a broad curriculum within the drug development process - from educational seminars to soft skills.

Frontiers in Drug Development Seminar - One day onsite seminars on new trends in drug development science.

E-Learning -Selected e-learning courses that provide an interactive environment for self-paced learning and can be booked at any time.

Study Trips - Yearly international study trips. A total of six study half-days are planned, which allow participants to experience a mix of theory and visits to institutions.

Courses offered by other Course Providers - Co-organized courses with other institutions, such as the University Hospital of Basel or partner universities. In addition, students also have the opportunity to choose courses offered by PharmaTrain Recognized Course Providers.

If you are interested in receiving information about our courses please subscribe to our ECPM newsletter.

09.02.2023 08:30

Bringing Medical Devices & Composition Products to the Market

More Information

Bringing Medical Devices & Combination Products to the Market

Over the past couple of years, digitalization has changed the pharma industry enormously and Medical Devices and Combination Products are becoming increasingly important. In this seminar, we will not only discuss the development and regulation of medical devices and combination products, but also the further essential steps to bring and maintain these products on the market. Moreover, we will get insights into guidance documents and information about what is needed and done in case there are quality challenges and recalls.
During this day, you will have the chance to discuss the advantages and risks of combination products regulated as medical devices and to see this important topic from the perspective of health insurance companies.
Join this seminar to discuss challenges and solutions on this interesting topic and get in close dialogue with key stakeholders.

About Frontiers in Drug Development Seminars

ECPM offers one day seminars on current topics, new trends and developments in drug development science. These seminars provide the opportunity to integrate work and further education, to discuss with experts face-to-face and to build an international network. They take place on the fourth day of each of the six modules of the Diploma Course and are mandatory for students taking the Diploma Course. Additionally they are open to our alumni and other interested scientists and can be booked separately.

Learning Outcomes

Participants will learn more about various topic such as:

  • Future trends in drug development including Future Information Technologies, Nano-Technologies, Computer Simulation and Modelling, Personalised Medicine, Genomics, Biologicals and Biosimilars, Advanced Therapeutics.
  • Regulatory Agency updates from FDA, EMA and Swissmedic.
  • Ethical, Economic and Epidemiological Considerations and Concepts in Drug Development.

Language

English

Program

One-day workshops, recognised for continuing professional development. The workshops are held on day four of each ECPM Course Module.

Credits

Six workshops over a period of two years, which equal 1 ECTS credit. Accredited as continuing education with eight cre- dits by the Swiss Society of Pharmaceutical Medicine (SGPM) and the Swiss Society of Pharmaceutical Profes- sionals (SwAPP). Accredited with 50 FPH-points in hospital pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

Fee

Course fee including certificate and electronic course mate- rial is CHF 680 and CHF 580 for ECPM Alumni and SwAPP/ SGPM members. The reduced fee for participants from academia and nonprofit organizations is CHF 210.
After registration you will receive an invoice. For short no- tice registration, please send a copy of the money transfer to ecpm@unibas.ch.

Cancellation Policy

Refund of fee will be given if cancellation is received in writing before the deadline for registration, after this date no refund can be given. Speakers are subject to change without notice.

Date and Venue

Thursday, February 9, 2023
Biozentrum, Spitalstrasse 41, 4056 Basel

Deadline for Registration

January 30, 2023

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Registration
ECPM Presentation and communicationSkill
Communicating more Powerfully and Persuasively
01.03.2023 08:00

Communicating more Powerfully and Persuasively

More Information

Course Description

This course is an intense two-day interactive, hands-on program designed to build and expand essential presentation skills from both content and delivery perspectives. Participants will learn how to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Participants should come ready to deliver a ten-minute presentation as well as a short story about a project in which they have been involved. Crucially, the story must include the type of obstacles that were faced, how they were overcome, the people or factors that helped or hindered along the way, together with the successes and failures and the outcome. Feedback from peers and the facilitators will help participants improve their ability to connect from both content and delivery perspectives.

Course Program

Day 1 – The process, establishing a baseline, stakeholders and messaging

  • Introduction to developing powerful presentations
  • Participants will deliver two presentations and receive direct feedback
  • Stakeholder definition, prioritization and analysis
  • Development of key messages

Day 2 – Storytelling, creating a narrative, and Q&A

  • Storytelling techniques
  • Structure and storyboard a presentation to address key stakeholders
  • Media techniques to confidently handle question and answer sessions
  • Delivery of final presentations by participants

Learning Outcomes

By the end of the course, participants will have a better understanding of how to:

  • Present in a more compelling way to internal and external stakeholders with increased confidence and capability
  • Use skills and techniques to:
    • Translate complex concepts into scalable and tailored messages for stakeholders
    • Develop engaging narratives using storytelling models that showcase and differentiate their science/project
    • Speak effectively to groups of any size face-to-face and online
    • Confidently handle question and answer sessions

Course Faculty

O’Patrick Wilson and Jennifer Sgueglia, O public relations GmbH, Ettingen, Switzerland

Target Audience

The course is designed for participants who want to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Course Language

English

    Course Credits

    The course including assessment provides 2 ECTS credits and a Certificate of Attendance by the University of Basel will be issued. The course is accredited with 100 FPH-points in hospital pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

    Course Date and Venue

    Planned in Spring 2023
    University of Basel

    Course Fee

    Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 1800.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    tba

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Methodological concepts of health economics
    Brochure Fundamentals in Health Economics
    09.03.2023 08:00

    Fundamentals in Health Economics

    More Information

    Course Description

    This course intends to provide the participants with an understanding of the key principles and methodological concepts of health economics. The role of health-economic thinking in the drug development process is addressed. Two group exercises will complement lectures and discussions.

    Course Program

    The program includes theoretical background sessions and is enriched with exercises and in-group exercises

    • Basic economic concept and principles
    • Health economic evaluations principles and methods
    • Health economic evaluation in drug development
    • Health technology assessments and reimbursement
    • Health economic evaluation alongside clinical trials and the need for modelling
    • Budget impact analysis – relevance, principles, and relationship with cost-effectiveness analysis

    Learning Outcomes

    At the end of the course, the participants will

    • Understand the fundamental concepts of health economics.
    • Understand key principles of health economic evaluation.
    • Be able to assess and appraise a published health economic analysis according to guidelines and checklists.
    • Understand the importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance.
    • Understand how policymakers set priorities in health care and how health economic evaluations support this process
    • Understand the importance of health technology assessment in different health care systems.
    • Understand rational choice and priority setting using economic evaluation.

    Course Faculty

    Prof. Thomas D. Szucs, MD MPH MBA LLM
    Michaela Barbier, PhD
    Arjun Bhadhuri, PhD
    Sandro Stoffel, PhD

    Judith Lupatsch, PhD
    Jana Bartakova, PhD


    Speakers from Pharmaceutical Industry

    Target Audience

    All pharmaceutical and health care professionals who are interested in getting a fundamental understanding of health economics and health economic evaluations in the context of drug development.

    Course Language

    English

      Course Credits

      The course including assessment provides 2 ECTS credits.

      Course Date and Venue

      March 9 & 10, 2023
      University of Basel, Biozentrum, Spitalstrasse 41, 4056 Base

      Course Fee

      Course fee including electronic course material, coffee breaks, lunch and certificate is CHF 1800.

      A reduced fee applies to participants from academia and nonprofit organizations. Please contact .

      Cancellation Policy

      Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

      Deadline for Registration

      February 24, 2023

      Course Organizer

      This course is organized by the European Center of Pharmaceutical Medicine.

      Registration
      ECPM Project Management in the Life Sciences Industry
      13.03.2023 08:00

      Project Management in the Life Sciences Industry

      More Information

      Course Description

      This course, offered in two parts of three days each, focuses on projects in the life sciences industry and the clinical trial setting, with the aim of bringing new treatments to patients successfully.

      These projects can range from early pre-clinical projects, to managing toxicology and Entry Into Human studies, large phase III clinical trials and post-marketing studies. All of them share a high complexity and require professional management at every level by experienced project managers who know the processes to reach the deliverables, can deal with multiple stakeholders simultaneously and deliver projects successfully often under a tight given budget and timelines.

      This highly interactive workshop setting includes a mixture of instructor led training and group work on real life cases. All templates and tools for planning, executing, managing & controlling as well as closing a project will be developed. In addition participants have the opportunity to discuss and work on an own project, identify its challenges and develop solutions or work on a model project provided by the course instructors.

      Course Program

      This course consists of two parts of three days each. A variety of teaching methods including lectures, exercises and interactive group discussions will be applied. A mandatory home assignment will complete the learning portfolio.

      The course covers the following topics:

      • Discussion of all project phases (initiation, planning, execution, monitoring & controlling, closure) and knowledge areas
      • Management of scope, time, cost, quality, team, communication, risk, procurement and stakeholders
      • Development of a project plan, starting from a project charter
      • Creation of documents and worksheets for managing clinical trials or other projects relating to pharmaceutical development
      • Discussion of Key Performance Indicators (KPIs) for project status
      • Discussion of Corrective Action Preventive Action (CAPAs) to prevent the project from getting off track

      Learning Outcomes

      At the end of the course, participants will

      • Understand the tasks and responsibilities of a project manager
      • Know the major project documents required for conducting projects successfully
      • Be acquainted with the tools to manage all knowledge areas throughout all project phases
      • Build, lead and manage effective project teams
      • Be familiar with the interactions needed with different project stakeholders
      • Have a series of templates and tools at hand
      • Be able to use and/or adapt these templates and tools within individual projects
      • Know how to practically apply different project management standards to all kinds of pharmaceutical development projects

      Course Faculty

      Adam Sobanski, MAIN5 Management Consulting, Frankfurt am Main, Germany

      Target Audience

      Specialists responsible for projects in the pharmaceutical industry, hospital or academic setting or regulatory authority. The course not only provides the tools and fundamentals for successful project management but also illustrates real life cases. Experienced managers are encouraged to bring their current issues so that solutions can be compiled during the course.

      Course Language

      English

        Course Credits

        The course including assessment provides 4 ECTS and a Certificate of Attendance by the University of Basel will be issued.

        Course Date and Venue

        • Part 1: March 13–15, 2023 and
        • Part 2: April 24–26, 2023
          University of Basel

        Course Fee

        Course fee including electronic course material, templates, lunch and coffee breaks is CHF 3000.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        February 24, 2023

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        ECPM Study Trip 2021
        Study Trip 2022 to Estland
        06.05.2023 09:00

        Study Trip 2023 to Estland

        More Information

        Background

        After the trips to Singapore (2015, 2016), Israel (2017), Denmark (2018), and Canada (2019) the destination of the study trip 2022 is Estland.

        Program
        A total of six study half-days are planned (theory and visits to institutions). The program will be available soon.

        • Introduction into the health system
        • Visits of hospitals
        • Insurance companies
        • Pharmaceutical industry

        The detailed program will be available by the end of January 2023. It includes an overview of the Estonian healthcare system where digitalization has been establishes since more than ten years. E-prescriptions and electronic patient dossiers are mandatory and video consultations and remote diagnoses have been integrated into outpatient care.

        Download Brochure »»

        Participants

        The study trip is intended for all experts working in public healthcare services. Minimum number of participants: 12 - 15 persons.

        Credits

        The trip provides 3 ECTS credits (rewarded after assignment has been accepted)

        Study Trip Fees

        Price varies according to country, registration and management via Max Künzi, 10% rebate for ECPM students. We reserve the right to change the program and/or the prices anytime.

        Registration

        For more information and registration please contact

        Contact

        Lic. iur. Max Künzi, MM | SAGG/SAHE | c/o Künzi Beratungen | Schachenstrasse 21 | Postfach 201 | 4702 Oensingen T (+41)(0)62 396 10 49 | F (+41)(0)62 396 24 10 | | www.sagg-sahe.ch | in cooperation with a travel agency.

        07.06.2023 08:00

        Genomics in Drug Development

        More Information

        Course Description

        Genomics in Drug Development is a specific and debated approach tailored to the individual patient’s genome.
        Because of the high cost of failures, insights that increase the probability of success of bringing a drug program to approval are critical to boost the productivity and efficiency of drug development. It has been proposed that using germline human genetics to drive drug discovery can overcome some of these issues. Drug targets with underlying human genetic support linked to their indication are 2-fold more likely to gain approval in the United States and European Union as compared with drug targets without human genetic support.

        To get to the point where Using Genetics and Genomics in Drug Discovery, Drug Development and further in Clinical Development can be achieved, there have to be set and defined regulations and addressed different questions regarding Ethical, Legal and Social Aspects as well as Data Safety and Data Protection.

        How far can we go? What is and can be ethically, legally and socially accepted? What about Genetics and Genomics in the evaluation of drug safety and where is the data stored safely? How is the intercultural, international and even further the intercontinental handling of the regulations and safety evaluation? How to handle Epidemiologic and Public Health related questions and how to deal with Genetics and Genomics in the future will be part of the Course and will be discussed and brought to the table.

        This Course brings together thought leaders and well-renowned experts from industry and academia. We will illuminate the topic in various ways, which allows you to get a deep insight to Genomics in Drug Development and a better understanding of its complexity.

        Join us on June 7 & 8, 2023 to learn from and discuss with the experts!

        Course Program

        Day 1
        Basics of Genetics / Genetic Testing Networks / Genetic Epidemiology and Public Health Genetics / Using Genetics and Genomics for Target Identification and Drug Discovery

        Day 2
        Using Genetics and Genomics in Clinical Development / Treatment of Genetic Diseases incl. Gene-Therapy / Genetics and Genomics in Drug Safety Evaluation / Ethical, Legal and Social Aspects incl. Data Protection Aspects

        Learning Outcomes

        By the end of the course, students will be able to:

        • understand Genetic Epidemiology and Public Health Genetics
        • know how Genetics and Genomics are used for Target Identification, Drug Discovery, in Clinical Development and in the Treatment of Genetic Diseases
        • have an overview of Genetics and Genomics in Drug Safety Evaluation
        • see the importance of Ethical, Legal and Social Aspects incl. Data Protection Aspects

        Course Faculty

        Tba

        Target Audience

        All pharmaceutical and health care professionals who are interested in getting a deeper understanding of genomics in medicines development.

        Course Language

        English

        Course Credits and Certificate

        Participation and submission of assignment result in a Certificate of Attendance by the University of Basel with 1 ECTS credit point and is also accredited with 100 FPH-points in hospital pharmacy and 100 FPH-points in clinical pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

         

        Course Date and Venue

        Basel, 7 & 8 June, 2023
        University of Basel, Biozentrum, Spitalstrasse 41, 4056 Basel, Switzerland

        Course Fee

        Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 1950.
        The reduced for participants from academia and nonprofit organizations is CHF 950.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        May 22, 2023

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        ECPM European University Network
        ECPM partner universities in the European University Network
        31.07.2023 08:10

        Other Courses by Pharmatrain

        More Information

        Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

        04.11.2024 08:30

        Ethical and Legal Aspects of Clinical Trials

        More Information

        Course Description

        The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

        Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

        Course Program

        Day 1
        The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

        Day 2
        Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

        Day 3
        Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

        Learning Outcomes

        By the end of the course, students will be able to:

        • Name key principles of ethical considerations during clinical research and development
        • Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
        • Understand international and national principles and guidelines which have to be followed when performing clinical trials

        Course Faculty

        tba

        Target Audience

        All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

        Course Language

        English

        Course Credits

        The course including assessment provides 2 ECTS credits and a Certificate of Attendance by the University of Basel will be issued.

        Course Date and Venue

        Basel, 4–6 November, 2024
        University of Basel

        Course Fee

        Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 2000.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        October 11, 2024

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-Learning: Basics in Health Economics

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • Fundamental concepts of health economics
        • Key elements of health economic evaluation
        • Assessment and analysis of a published health economic study
        • The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
        • How policymakers set priorities in health care and how health economic evaluations support this process

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-learning: Drug Safety and Pharmacovigilance

        More Information

        Course Description

        This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • The role of drug safety in the successful development and usage of a medicine to the benefit of patients
        • Which safety-related questions need to be answered in early and late drug development
        • Tools, techniques, and methodologies used in drug safety evaluation
        • What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
        • How changes in safety assessment could become part of a new drug development paradigm

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-Learning: Personalized Health Care

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

        Learning Outcomes

        At the end of the course, the participants should be able to:

        • Understand the biological and clinical concepts of personalized medicine
        • Understand the benefits and pitfalls of individualized therapies for patients
        • Comprehend the basic elements of predictive and prognostic interventions
        • Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
        • Understand pharmacogenetic and pharmacogenomic implications
        • Be aware of the strategies of R&D processes with personalized drugs
        • Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
        • Determine legal, regulatory and ethical aspects of personalised medicine

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration